TREATMENT OF OVARIAN CARCINOMA - POSSIBILITIES FOR PROGRESS

[1] 5 YEARS CLINICAL EXPERIENCE WITH 5-FLUOROURACIL [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (04): : 295 - +

[2] AURE JC, 1971, OBSTET GYNECOL, V37, P1

[3] BARNES P H, 1958, Can Med Assoc J, V79, P416

[4] BARR W, 1970, Scottish Medical Journal, V15, P250

[5] BECK RE, 1968, CAN MED ASSOC J, V98, P539

[6] Brandl K, 1970, Zentralbl Gynakol, V92, P233

[7] CZERNOBI.B, 1970, CANCER-AM CANCER SOC, V26, P1142, DOI 10.1002/1097-0142(197011)26:5<1141::AID-CNCR2820260526>3.0.CO

[8] 2-R

[9] RADIOTHERAPY IN MALIGNANT DISEASE OF OVARY [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (04): : 359 - &

[10] DAVIS BA, 1956, SURG GYNECOL OBSTET, V102, P565

[1] 5 YEARS CLINICAL EXPERIENCE WITH 5-FLUOROURACIL [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (04): : 295 - +

[2] AURE JC, 1971, OBSTET GYNECOL, V37, P1

[3] BARNES P H, 1958, Can Med Assoc J, V79, P416

[4] BARR W, 1970, Scottish Medical Journal, V15, P250

[5] BECK RE, 1968, CAN MED ASSOC J, V98, P539

[6] Brandl K, 1970, Zentralbl Gynakol, V92, P233

[7] CZERNOBI.B, 1970, CANCER-AM CANCER SOC, V26, P1142, DOI 10.1002/1097-0142(197011)26:5<1141::AID-CNCR2820260526>3.0.CO

[8] 2-R

[9] RADIOTHERAPY IN MALIGNANT DISEASE OF OVARY [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (04): : 359 - &

[10] DAVIS BA, 1956, SURG GYNECOL OBSTET, V102, P565